WO2014076714A3 - Shigella vaccin - Google Patents

Shigella vaccin Download PDF

Info

Publication number
WO2014076714A3
WO2014076714A3 PCT/IN2013/000703 IN2013000703W WO2014076714A3 WO 2014076714 A3 WO2014076714 A3 WO 2014076714A3 IN 2013000703 W IN2013000703 W IN 2013000703W WO 2014076714 A3 WO2014076714 A3 WO 2014076714A3
Authority
WO
WIPO (PCT)
Prior art keywords
shigella
vaccin
pgiv
pgi
vaccine
Prior art date
Application number
PCT/IN2013/000703
Other languages
French (fr)
Other versions
WO2014076714A2 (en
Inventor
Neelam Taneja
Sapna Pahil
Meera Sharma
Original Assignee
Indian Council Of Medical Research
Post-Graduate Institute Of Medical Education And Research (Pgimer)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indian Council Of Medical Research, Post-Graduate Institute Of Medical Education And Research (Pgimer) filed Critical Indian Council Of Medical Research
Priority to US14/443,555 priority Critical patent/US9636390B2/en
Publication of WO2014076714A2 publication Critical patent/WO2014076714A2/en
Publication of WO2014076714A3 publication Critical patent/WO2014076714A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A vaccine for protection against multiple serotypes of Shigella sp., comprising a putative heat shock protein (EL PGI II), and Hypothetical Protein (EL PGIV).
PCT/IN2013/000703 2012-11-19 2013-11-19 Novel immunogenic antigens of shigella WO2014076714A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/443,555 US9636390B2 (en) 2012-11-19 2013-11-19 Immunogenic antigens of shigella

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3543/DEL/2012 2012-11-19
INDE35432012 2012-11-19

Publications (2)

Publication Number Publication Date
WO2014076714A2 WO2014076714A2 (en) 2014-05-22
WO2014076714A3 true WO2014076714A3 (en) 2015-01-08

Family

ID=49956291

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2013/000703 WO2014076714A2 (en) 2012-11-19 2013-11-19 Novel immunogenic antigens of shigella

Country Status (1)

Country Link
WO (1) WO2014076714A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011036564A2 (en) * 2009-09-28 2011-03-31 Novartis Vaccines Institute For Global Health Srl Hyperblebbing shigella strains

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011036564A2 (en) * 2009-09-28 2011-03-31 Novartis Vaccines Institute For Global Health Srl Hyperblebbing shigella strains

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARRY EILEEN M ET AL: "Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.", VACCINE 1 MAY 2006, vol. 24, no. 18, 1 May 2006 (2006-05-01), pages 3727 - 3734, XP002732509, ISSN: 0264-410X *

Also Published As

Publication number Publication date
WO2014076714A2 (en) 2014-05-22

Similar Documents

Publication Publication Date Title
EP2982681B8 (en) Wt1-antigen peptide conjugate vaccine
EP2706991A4 (en) Multiple antigen presenting immunogenic composition, and methods and uses thereof
HK1215376A1 (en) N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4- dihydropyrimidine-1 (2h)-carboxamides derivatives n-()-5--4--3--2--34--1(2h)-
EP2996506A4 (en) Helmet padding system
BR112015003259A2 (en) compound, pharmaceutical composition, and vaccine composition.
DK2498636T3 (en) Protective helmet, especially for forest workers
ZA201503467B (en) M. tuberculosis vaccines
MX2013013801A (en) Immunostimulatory oligodeoxynucleotides.
EP3348269A4 (en) Mevalonate pathway inhibitor as highly-effective vaccine adjuvant
MX346596B (en) Immunostimulatory oligodeoxynucleotides.
ZA201608487B (en) Dual adjuvant vaccine compositions, preparation and uses
DK3071212T3 (en) Extract from algae for use as immunomodulatory agent
EP3049092A4 (en) Compositions, methods and kits for eliciting an immune response
EP3010340A4 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
DK2955192T3 (en) Anti-mycoplasma spp. subunit vaccine
IL236712A0 (en) Di-and tri-heteroaryl derivatives, compositions comprising same and uses thereof
EP2839615A4 (en) Launch delay offset data flow protection
IL251177A0 (en) Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
EP3075393A4 (en) Adjuvant composition, vaccine composition comprising same, and method for producing same
EP2837627A4 (en) Amidopyridine derivative, and use thereof
EP2822654A4 (en) Orally active, cell-penetrating homing peptide and methods of using same
EP3057611A4 (en) Thermostable respiratory synctial virus (rsv) vaccine compositions
EP2929894A4 (en) Vaccination adjuvant, and preparation and vaccines containing same
EP3389643A4 (en) Novel muramyl peptide derivative compound, synthesis and uses thereof
EP3387005A4 (en) Novel muramyl peptide derivative compound, synthesis and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13821194

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14443555

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 13821194

Country of ref document: EP

Kind code of ref document: A2